Alberta study offers free medication for low-income seniors
If you're a senior on a fixed income, Calgary researchers are trying to determine if drug co-payments are a barrier to seniors (with chronic health condition) acheiving optimal health. For more info: www.accesstrial.ca - you can also call 1-844-944-8927 if you want to participate in the study.
April 4, 2016 on Clinical Trial Results TV
Dr. Ross Tsuyuki and Dr. C. Michael Gibson Discuss: The Effect of Community Pharmacist Prescribing and Care on Cardiovascular Risk Reduction: The RxEACH Multicenter Randomized Controlled Trial.
Early intervention to prevent clotting during kidney dialysis not always best
Dialysis is the most common treatment for people with kidney failure worldwide. But the process, which involves hooking up patients at least three times a week to a machine that cleans their blood, can be painful, time-consuming, and sometimes ineffective.
For dialysis to occur, a physician must create entry to the bloodstream, called vascular access. Researchers from the University of Calgary's Cumming School of Medicine reviewed different methods available to achieve the most effective use of the vascular access. Results from this study were recently published in the Cochrane Library.
In the News (Edmonton)
New GN Clinic in Edmonton (under Northern Alberta Renal Program (NARP)) is creating a single point of access for all patients in the region with rare diseases by matching patients with state-of-the-art multidisciplinary care and ongoing clinical trials. Read the article here.
New Alberta Health Services Board features strong health care expertise
Minister of Health Sarah Hoffman has created a new board to govern Alberta Health Services and further stabilize Alberta's health-care system.
The organization has been without a board since 2013.
The new board is made up of:
- Linda Hughes (Chair)
- Dr. Brenda Hemmelgarn (vice-chair)
- David Carpenter
- Hugh D. Sommerville
- Marliss Taylor
- Glenda Yeates
Richard Dicerni, Deputy Minister of Executive Council with the Government of Alberta, will also serve on the board.
To view the news release, click here.
To watch the news conference, click here.
Researchers evaluate systemic cost of high blood pressure in Alberta
Approximately 21 percent of adults in Alberta were diagnosed with hypertension, or high blood pressure, in 2010, and an estimated nine in 10 people who live an average lifespan will develop the confition in their lifetime.
Hypertension is a major risk factor for heart disease and stroke - common, deadly and costly diseases. New research out of the Cumming School of Medicine, published in the September issue of the journal, Hypertension, evaluated the economic impact of hypertension in Alberta. In fact, high blood pressure is the leading risk for death and disability globally, and reducing uncontrolled hypertension is one of none United Nations targets to reduce non-communicable disease.
Researchers hope that this information will be used as a driving force to implement policies aimed at improving treatment and prevention of hypertension.
To read the full article, click here.
University receives $39.1 million for health research
Research dedicated to better health for Canadians is getting a $39.1-million boost at the University of Calgary through the Government of Canada's Canadian Institutes of Health Research (CIHR).
The following ICDC Researchers have received funding.
Matthew James ($855, 843): "Better Prediction and Decision Support Tools to Improve Care and Outcomes for Patients with Acute Kidney Injury." Member of the Libin and O'Brien Institutes, Assistant Professor in the Departments of Community Health Sciences and Medicine, Cumming School of Medicine.
Marcello Tonelli ($2,941,008): "Patient-Centered Care of Comorbidity for People with Chronic Kidney Disease." Member of the O'Brien and Libin Institutes, Professor in the Department of Medicine, Cumming School of Medicine.
To read the full article, click here.
New pharmacy program identifies patients at risk for vascular disease
The RxEACH program helps pharmacists across the province to identify patients at risk of developing vascular diseases, such as heart attack and stroke, and to implement management strategies.
For more information, click here.
Standardized care for Albertans with chronic kidney disease (CKD)
Albertans living with chronic kidney disease (CKD) are receiving improved diagnosis and treatment following the launch of a standardized care pathway in October 2014.
Developed by Alberta researchers, the CKD Clinical Pathway provides community physicians, pharmacists and nurses an online resource that can be used to shape care plans for the one-in-10 Alberta adults with chronic kidney disease. Read the Cummings School of Medicine press release in News Digest.
Watch the CTV Calgary interview video
CIHR-CMAJ Top Canadian Achievements in Health Research Award:
March 18, 2013- The ICDC team is a proud recipient of the CIHR-CMAJ Top Canadian Achievements in Health Research Award for their research and knowledge translation activities which contributed to great improvements in the treatments of hypertension, diabetes, chronic kidney disease and vascular disease.
For more information on the CIHR-CMAJ Top Canadian Achievements in Health Research Awards please click here Click here
Alberta Health Services (AHS) President’s Excellence Award
On May 7, 2012, the ICDC team under Dr. Brenda Hemmelgarn, Dr. Braden Manns and Dr. Marcello Tonelli was given the AHS President's Excellence Award for outstanding achievements in research for improving the health of patients living with or at risk of chronic disease. The President's Excellence Award was established to recognize the work of AHS staff and physicians in improving the quality of care for Albertans and safeguarding patients and staff safety.
To view the poster of the 3 award recipients click here.
For more information on the President’s Excellence Award click here.